{"id":"W4416265857","doi":"10.1016/j.ejca.2025.116106","title":"Corrigendum to “Talazoparib plus enzalutamide in metastatic castration-resistant prostate cancer: Safety analyses from the randomized, placebo-controlled, phase III TALAPRO-2 study” [Eur J Cancer 213 (December) (2024) 115078]","year":2025,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Enzalutamide; Incidence (geometry); Prostate cancer; Cancer; Population; Regret","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.003349007,0.0005263131,0.002174129,0.0005187562,0.000292671,0.0001874674,0.000486244,0.0000364466,0.001096424],"category_scores_gemma":[0.0004939206,0.000298698,0.0005125458,0.001138769,0.0002361172,0.0002329701,0.000134912,0.0008712767,0.00001561391],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00136558,"about_ca_system_score_gemma":0.002929695,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.007496887,"about_ca_topic_score_gemma":0.01235411,"domain_scores_codex":[0.9935458,0.00201353,0.002088634,0.0005570561,0.00111809,0.0006768791],"domain_scores_gemma":[0.9968035,0.0006128438,0.0008795514,0.0004854149,0.0008288975,0.0003898512],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9029534,0.0009109413,0.005308216,0.0001032756,0.007407833,0.003099089,0.007806834,0.009881759,0.00851188,0.00001524246,0.02203223,0.03196923],"study_design_scores_gemma":[0.9478624,0.001249701,0.01108734,0.002234231,0.005519175,0.0000249772,0.005479485,0.001407954,0.002818589,0.00004419352,0.02180214,0.0004697512],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8944521,0.07885256,0.0004012214,0.01124781,0.003195812,0.007577783,0.000516444,0.0000335853,0.003722704],"genre_scores_gemma":[0.9576395,0.009798274,0.0001596471,0.001035238,0.0005922086,0.0006862401,0.00002218474,0.00007534913,0.02999139],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06905429,"threshold_uncertainty_score":0.9999465,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05618062700535024,"score_gpt":0.4033525715823855,"score_spread":0.3471719445770352,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}